Navigation Links
Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
Date:10/23/2008

SAN DIEGO, Oct. 23 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the BIOCOM Investor Conference in San Diego on Tuesday, October 28, 2008 at 10:30 a.m. PT. Mark G. Foletta, Amylin's Senior Vice President of Finance and Chief Financial Officer, will be providing a corporate overview.

The live presentation will be Web cast, and a recording will be made available following the event. The Web cast and recording will be accessible through Amylin's corporate Web site, located at http://www.amylin.com. To access the live Web cast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California with over 2,000 employees nationwide. Further information on Amylin Pharmaceuticals is available at http://www.amylin.com.


'/>"/>
SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Lilly and Amylin Enter Into Supply Agreement for Exenatide Once Weekly
2. Amylin Pharmaceuticals Reports Third Quarter Financial Results
3. Amylin Pharmaceuticals to Webcast Third Quarter Results
4. Amylin Pharmaceuticals to Present at Thomas Weisel Healthcare, BioCentury NewsMakers, and Morgan Stanley Global Healthcare Conferences
5. Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA
6. Amylin and Lilly Set Date and Time for Conference Call
7. Amylin Pharmaceuticals to Webcast Second Quarter Results
8. Amylin Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference
9. Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008
10. Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
11. Amylin Pharmaceuticals to Present at FBR Capital Markets Investor Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...swire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nas...the fourth quarter ended December 31, 2009 of appr...n for the fourth quarter of 2008. Included in four...llment payments of $12.5 million from Alexion. Al...ne-time $1.8 million payment from Genentech for th...
(Date:12/1/2009).../ -- Harvest Technologies Corp. ( www.harvesttech....nsored 60-patient clinical trial conducted at Sri ... the company,s BMAC System to treat patients with ...Sri Ramachandra Medical Center is a Harvard Medica...ennai, India and one of the largest private health...
(Date:12/1/2009)...e/ -- Expanding its European reach for bacterial p...ppointed Lake Chemicals and Minerals of England as...gham, England. ,, Osprey breeds trillions of b...aste water, and environmental markets. Its bacteri...and clean up industrial and marine spills. In agri...
(Date:12/1/2009)...nounced a collaborative research agreement with Ro...ng EpiVax’s proprietary Tregitope technology...e responses to certain drugs. In the course of the...technology will be evaluated for its effect on the... (Vocus) December 2, 2009 -- To...
Breaking Biology Technology:PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3
...chnology Conference Brings Together,Policy and Inn...eading health,care economists and physician-innova...dical technology for improving patient care and he...on, entitled "Value of Medical,Technology: Innovat... the,premier medical technology conference and exh...
...c., announced today that,it has appointed Joao Sif...hief medical officer. Dr. Siffert will be responsi...s and Alzheimer,s diseases and will report,to Raym...dent of clinical,and preclinical R&D and chief ope...ce in clinical development to Ceregene,as he has m...
...ctober 2 - Management and Distinguished Scientis...nd Therapeutic Development Programs, as Well as on...q: ROSG ), a global leader in,microRNA-based diag...host,its R&D Day on microRNAs and their significan...applications. This event will take place on,Friday...
Other Biology Technology:Top Health Care Economists and Physician-Innovators Discuss Value of Medical Technology at AdvaMed 2007 Conference 2Top Health Care Economists and Physician-Innovators Discuss Value of Medical Technology at AdvaMed 2007 Conference 3Ceregene Appoints Joao Siffert, M.D. to the Position of Chief Medical Officer 2Ceregene Appoints Joao Siffert, M.D. to the Position of Chief Medical Officer 3Rosetta Genomics Will Host and Webcast its R&D Day on Friday, October 26, 2007 2Rosetta Genomics Will Host and Webcast its R&D Day on Friday, October 26, 2007 3Rosetta Genomics Will Host and Webcast its R&D Day on Friday, October 26, 2007 4
(Date:12/1/2009)...h. -- Time-lapsed video of individual breast tissu...ife of a cell: a protein that cycles between two m...searchers a more complete view of the internal sig...s that go awry in cancer and are targets of drug d...s respond to growth factors, travels back and fort...
(Date:12/1/2009)... just for listening to the radio anymore. They,re .... Research from North Carolina State University is...ting shape-shifting antennas that open the door to...safety to military deployment. , Modern antennas...re limitations to how far they can be bent and ho...
(Date:11/30/2009)...organisation is needed to monitor the commitments ...hagen to cut their deforestation rates, according ...ng government agencies and research groups have fa...e images of the Earth,s surface collected each wee...published by Dr Alan Grainger in the Proceedings ...
Breaking Biology News(10 mins):ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 2ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 3ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 4Shape shifters: Researchers create new breed of antennas 2World forest observatory needed to monitor vital role of forests in climate deal 2New Momentum Teams With Oracle to Help Reduce Counterfeiting in the Life Sciences Industry 5248 1New Momentum Teams With Oracle to Help Reduce Counterfeiting in the Life Sciences Industry 5248 2Ethnic background may be associated with diabetes risk 58933 1Ethnic background may be associated with diabetes risk 58933 2Optical Express Launches Television Advertisement for the Cosmetic Clinic 58929 1Optical Express Launches Television Advertisement for the Cosmetic Clinic 58929 2Optical Express Launches Television Advertisement for the Cosmetic Clinic 58929 3
...nt combining,nanoparticle and gene silencing techn...irus (RSV) -- a virus associated with severe,bronc... South Florida,researchers found. The study was re...ture Medicine.,RSV infects lung cells and can be l...y and those with compromised immune systems. No,va...
... to play a crucial role in the manufacture of a pr...team of researchers led by scientists at the Natio...t of the National Institutes of Health. , The pro...ain-derived neurotrophic factor. In an earlier stu...at mBDNF is essential for the formation of long-te...
...TechTransfer,recently licensed software that will ...nst disease.,The software, known as Rosetta, predi...valuable to biological and biomedical researchers....tta software without,charge to the Institute for S...zation. The institute has partnered with IBM and U...
Other Biology News:Novel antiviral technology inhibits RSV infection in mice 2Researchers Uncover Key Step In Manufacture of Memory Protein 2UW's Rosetta software to unlock secrets of many human proteins 2
Mouse Anti-ENDOTHELIAL CELLS (LUNG ASSOCIATED ANTIGEN) Monoclonal Antibody, Unconjugated, Clone H4-7/33 from AbD Serotec
Canine IL-10 ELISA Kit from R&D Systems
EGTA from GE Healthcare, formerly Amersham Biosciences
Rat Anti-Rat RT1Au (Class I Polymorphic) Monoclonal Antibody, Unconjugated from AbD Serotec
Biology Products: